AmirAli Talasaz - 31 Dec 2025 Form 5 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz
Issuer symbol
GH
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
5
Filing time
22 Jan 2026, 17:44:02 UTC
Previous filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Talasaz AmirAli Co-Chief Executive Officer, Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz 22 Jan 2026 0001753159

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Other $0 -2,000,248 -99% $0.000000 13,209 31 Dec 2025 Direct F1
transaction GH Common Stock Other $0 -82,854 -100% $0.000000 0 31 Dec 2025 Shares held by Talasaz Investments, L.P. F2
transaction GH Common Stock Other $0 +2,000,248 $0.000000 2,000,248 31 Dec 2025 Shares held by Talasaz and Eskandari 2017 Family Trust F1
transaction GH Common Stock Other $0 +82,854 +4.1% $0.000000 2,083,102 31 Dec 2025 Shares held by Talasaz and Eskandari 2017 Family Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects changes in form of ownership from direct to indirect due to transfer of shares to Talasaz and Eskandari 2017 Family Trust.
F2 Reflects changes in form of ownership from Talasaz Investments LP due to the transfer of shares to Talasaz and Eskandari 2017 Family Trust.